Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases

Stem Cells

Volumn 24, Issue 5, 2006, Pages 1254-1264

  Son, Bo Ra ^a   Marquez Curtis, Leah A ^b   Kucia, Magda ^c   Wysoczynski, Marcin ^c   Turner, A Robert ^a   Ratajczak, Janina ^c   Ratajczak, Mariusz Z ^c   Janowska Wieczorek, Anna ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CANADIAN BLOOD SERVICES   (Canada)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Bone marrow; Cord blood; Gene expression; Matrix metalloproteinases; Membrane type 1 matrix metalloproteinase; Mesenchymal stem cells

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; GELATINASE A; MATRIGEL; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14; MESSENGER RNA; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; STROMAL CELL DERIVED FACTOR 1; VASCULAR ENDOTHELIAL CADHERIN;

ARTICLE; BONE MARROW; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TISSUE INJURY; UMBILICAL CORD BLOOD;

BIOLOGICAL MARKERS; CELL CULTURE TECHNIQUES; CELL MOVEMENT; CELLS, CULTURED; CHEMOKINE CXCL12; CHEMOKINES, CXC; FETAL BLOOD; GENE EXPRESSION; HEPATOCYTE GROWTH FACTOR; HUMANS; MATRIX METALLOPROTEINASES; MESENCHYMAL STEM CELLS; PROTO-ONCOGENE PROTEINS C-MET; RECEPTORS, CXCR4;

EID: 33749078198     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2005-0271     Document Type: Article

References (57)

1. Le Blanc K, Pittenger MF. Mesenchymal stem cells: Progress toward promise. Cytotherapy 2005;7:36-45.
2. Tocci A, Forte L. Mesenchymal stem cells: Use and perspectives. Hematol J 2003;4:92-96.
3. Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: Paradoxes of passaging. Exp Hematol 2004;32:414-425.
4. Taichman RS. Blood and bone: Two tissues whose fates are inter-twined to create the hematopoietic stem-cell niche. Blood 2005;105:2631-2639.
5. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: Characterization, differentiation, and application in cell and gene therapy. J Cell Mol Med 2004;8:301-316.
6. Chiu RCJ. Bone-marrow stem cells as a source for cell therapy. Heart Fail Rev 2003;8:247-251.
7. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
8. Villaron EM, Almeida J, Lopez-Holgado N et al. Mesenchymal stem cells are present in peripheral blood and can engraft after allogeneic hematopoietic stem cell transplantation. Haematologica 2004;89:1421-1427.
9. Horwitz EM, Gordon PL, Koo WKK et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of the bone. Proc Natl Acad Sci U S A 2002;99:8932-8937.
10. Koc ON, Gerson SL, Cooper BW et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000;18:307-316.
11. Chapel A, Bertho JM, Bensidhoum M et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiation-induced multi-organ failure syndrome. J Gene Med 2003;5:1028-1038.
12. Kawada H, Fujita J, Kinjo K et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood 2004;104:3581-3587.
13. Nagaya N, Fujii T, Iwase T et al. Intravenous administration of mesenchymal stem cells improves cardiac function in rats with acute myocardial infarction through angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol 2004;287:H2670-H2676.
14. Ponomaryov T, Peled A, Petit I et al. Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function. J Clin Invest 2000;106:1331-1339.
15. Kollet O, Shivtiel S, Chen YQ et al. HGF, SDF-1, and MMP-9 are involved in stress-induced human CD34+ stem cell recruitment to the liver. J Clin Invest 2003;112:160-169.
16. Jankowski K, Kucia M, Wysoczynski M et al. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. Cancer Res 2003;63:7926-7935.
17. Ratajczak MZ, Kucia M, Reca R et al. Stem cell plasticity revisited: CXCR4-positive cells expressing mRNA for early muscle, liver and neural cells 'hide out' in the bone marrow. Leukemia 2004;18:29-40.
18. Kucia M, Ratajczak J, Reca R et al. Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury. Blood Cells Mol Dis 2004;32:52-57.
19. + progenitors to peripheral blood. J Exp Med 1997;185:111-120.
20. Zou YR, Kottmann AH, Kuroda M et al. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature 1998;393:595-599.
21. Peled A, Petit I, Kollet O et al. Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4. Science 1999;283:845-848.
22. + progenitors increases their proliferation, migration and NOD/SCID repopulation. Blood 2004;103:2942-2949.
23. Grabovsky V, Feigelson S, Chen C et al. Subsecond induction of alpha4 integrin clustering by immobilized chemokines stimulates leukocyte tethering and rolling on endothelial vascular cell adhesion molecule 1 under flow conditions. J Exp Med 2000;192:495-506.
24. Kijowski J, Baj-Krzyworzeka M, Majka M et al. The SDF-1-CXCR4 axis stimulates VEGF secretion and activates integrins but does not affect proliferation and survival in lymphohematopoietic cells. STEM CELLS 2001;19:453-466.
25. + cells in response to chemokines. Exp Hematol 2000;28:1274-1285.
26. Nishino T, Hisha H, Nishino N et al. Hepatocyte growth factor as a hematopoietic regulator. Blood 1995;85:3093-3100.
27. Ding S, Merkulova-Rainon T, Han ZC et al. HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. Blood 2003;101:4816-4822.
28. Neuss S, Becher E, Woltje M et al. Functional expression of HGF and HGF receptor/c-met in adult human mesenchymal stem cells suggests a role in cell mobilization, tissue repair, and wound healing. STEM CELLS 2004;22:405-414.
29. + cells and their transmigration through reconstituted basement membrane. Blood 1999;93:3379-3390.
30. Yamakawa S, Asai T, Uchida T et al. (-)-Epigallocatechin gallate inhibits membrane-type 1 matrix metalloproteinase, MT1-MMP, and tumor angiogenesis. Cancer Lett 2004;210:47-55.
31. Janowska-Wieczorek A, Matsuzaki A, Marquez LA. The hematopoietic microenvironment: Matrix metalloproteinases in the hematopoietic microenvironment. Hematology 2000;4:515-527.
32. Gronthos S, Zannettino ACW, Hay SJ et al. Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J Cell Sci 2003;116:1827-1835.
33. Romanov YA, Svintsitskaya VA, Smirnov VN. Searching for alternative sources of postnatal human mesenchymal stem cells: Candidate MSC-like cells from umbilical cord. STEM CELLS 2003;21:105-110.
34. Panepucci RA, Siufi JL, Silva WA Jr et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. STEM CELLS 2004;22:1263-1278.
35. Bieback K, Kern S, Kluter H et al. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. STEM CELLS 2004;22:625-634.
36. Lee OK, Kuo TK, Chen WM et al. Isolation of multipotent mesenchymal stem cells from umbilical cord blood. Blood 2004;103:1669-1675.
37. Yang SE, Ha CW, Jung MH et al. Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy 2004;6:476-486.
38. Liechty KW, Mackenzie TC, Shaaban AF et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000;6:1282.
39. Jiang Y, Jahagirdar BN, Reinhardt RL et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-49.
40. Keene CD, Ortiz-Gonzalez XR, Jiang Y et al. Neural differentiation and incorporation of bone marrow-derived multipotent adult progenitor cells after single cell transplantation into blastocyst stage mouse embryos. Cell Transplant 2003;12:201-213.
41. Schwartz RE, Reyes M, Koodie L et al. Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells. J Clin Invest 2002;109:1291-1302.
42. Kucia M, Reca R, Jala VR et al. Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells. Leukemia 2005;19:1118-1127.
43. Ji JF, He BP, Dheen T et al. Interactions of chemokines and chemokines receptors mediate the migration of mesenchymal stem cells to the impaired site in the brain after hypoglossal nerve injury. STEM CELLS 2004;22:415-427.
44. Kortesidis A, Zannettino A, Isenmann S et al. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 2005;105:3793-3801.
45. Wynn RF, Hart CA, Corradi-Perini C et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004;104:2643-2645.
46. + hematopoietic progenitor cells. STEM CELLS 2004;22:1015-1029.
47. Wysoczynski M, Reca R, Ratajczak J et al. Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient. Blood 2005;105:40-48.
48. Ono K, Matsumori A, Shioi T et al. Enhanced expression of hepatocyte growth factor/c-met by myocardial ischemia and reperfusion in a rat model. Circulation 1997;95:2552-2558.
49. + cells to an SDF-1 gradient. Blood 2004;104:2889a.
50. Avigdor A, Schwartz S, Goichberg P et al. Membrane type 1-matrix metalloproteinase is directly involved in G-CSF-induced human hematopoietic stem and progenitor cells mobilization. Blood 2004;104:2675a.
51. Matias-Roman S, Galvez BG, Genis L et al. Membrane type 1-matrix metalloproteinase is involved in migration of human monocytes and is regulated through their interaction with fibronectin or endothelium. Blood 2005;105:3956-3964.
52. Robinet A, Fahem A, Cauchard JH et al. Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP. J Cell Sci 2005;118:343-356.
53. Annabi B, Lee Y-T, Turcotte S et al. Hypoxia promotes murine bone marrow-derived stromal cell migration and tube formation. STEM CELLS 2003;21:337-347.
54. Sabeh F, Ota I, Holmbeck K et al. Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP. J Cell Biol 2004;167:769-781.
55. Kajita M, Itoh Y, Chiba T et al. Membrane-type 1 matrix metalloproteinase cleaves CD44 and promotes cell migration. J Cell Biol 2001;153:893-904.
56. Ratnikov BI, Rozanov DV, Postnova TI et al. An alternative processing of integrin alpha V subunit in tumor cells by membrane type I matrix metalloproteinase. J Biol Chem 2002;277:7377-7385.
57. Belkin AM, Akimov SS, Zaritskaya LS et al. Matrix-dependent proteolysis of surface transglutaminase by membrane-type metalloproteinase regulates cancer cell adhesion and locomotion. J Biol Chem 2001;276:18415-18422.